1. Introduction {#sec1}
===============

Neonatal hypoxic-ischemia (HI) occurs when oxygen supply and blood flow are not stable during the prenatal and postnatal periods, and this condition causes the most common form of cerebral palsy \[[@B1], [@B2]\]. Neonatal HI can cause death or brain damage leading to loss of motor ability, sensory function, and cognitive function throughout life \[[@B1], [@B2]\]. HI injury is characterized by sequential occurrences, with damage in the early phase involving cytotoxic edema, acute lysis, and oxidative stress. Later phases of HI response include inflammatory activity, apoptosis, necrosis, and long-term neural tissue repairing or remodeling \[[@B3], [@B4]\]. It was reported that 10 to 50% of patients who survived neonatal HI usually lost motor function, and 20 to 50% have lost sensory function or cognitive function \[[@B2], [@B5]\]. Despite the high incidence of neonatal HI, there is still no effective treatment for this form of injury.

In general, hemiplegia after HI has been treated by various methods, such as physical therapy, surgical treatment, and pharmacological treatment. These methods help to prevent muscular rigidity and to overcome impairment by training the patient to make skilled movements \[[@B6], [@B7]\]. Constraint-induced movement therapy (CIMT), one of the available physical therapies for rehabilitation, can induce functional recovery from hemiplegia caused by CNS injury \[[@B8]\]. CIMT inhibits the use of the normal arm and thus improves functional movement by encouraging the use of the damaged arm \[[@B9]\]. CIMT has been reported to induce neurological changes through neuroplasticity reorganization in adult HI patients, children HI patients, and animal models \[[@B10]--[@B12]\]. Further, it has been reported to improve motor function of the affected forelimb \[[@B13], [@B14]\]. Various modifications have been made for children undergoing CIMT because children can lack motivation and require special attention \[[@B15], [@B16]\]. Further, the efficacy of CIMT in children has been shown to be related to the type and severity of the disability \[[@B8], [@B17]\].

Electroacupuncture (EA) is a procedure that involves applying needles to acupuncture points and applying electrical stimulation. EA has been shown to be an effective treatment in stroke rehabilitation and hemiplegia \[[@B18]\]. Further, it has also been shown to improve not only behavioral but also neurological damage \[[@B19]--[@B21]\]. EA promotes neuroprotection and functional recovery in HI injury \[[@B20], [@B22]\]. In addition, previous animal studies have suggested that the therapeutic effects of EA are more pronounced when it is combined with exercise therapy \[[@B23]\]. The combined treatment of EA at Baihui (GV 20) and Zusanli (ST 36) along with administration of polysaccharide of Gastrodia Elata Blume was shown to increase the expression of growth factors and stem cell factor in ischemic lesions, suggesting that this combination may have the potential to repair neurological function \[[@B24]\].

We recently reported that CIMT yielded a modest recovery of motor function in a rat model of neonatal HI \[[@B25]\]. In the current study, we aimed to determine whether a combination of CIMT and EA is effective in treating HI in neonatal rats. We thus investigated behavioral improvements as well as histological changes following a combination of CIMT and EA.

2. Materials and Methods {#sec2}
========================

2.1. Animals {#sec2.1}
------------

On day 17 (E17) of pregnancy, Sprague-Dawley rats (Doo Yeol Biotech, Seoul, Korea) were housed at 22°C under alternating 12-hour light/dark cycles. Water and food were provided ad libitum. All animal experiments followed the institutional guidelines of the Pusan National University-Institutional Animal Care and Use Committee on ethical procedures and scientific care, and all experiments were approved in advance by the institutional review board of Pusan National University (Permit number: PNU-2015-0939). Rat pups were assigned into groups using computer-generated randomization. This computer-generated randomization method assigned animals into either a sham group (*n* = 10) or an HI injury group (*n* = 36). Two weeks after inducing HI, the HI rats were randomly assigned into four groups: (1) HI injury group with no treatment (HI: *n* = 9), (2) HI injury and CIMT (CIMT: *n* = 9), (3) HI injury and EA treatment (EA: *n* = 9), and (4) HI injury and combined CIMT and EA treatment (CIMT + EA: *n* = 9). [Figure 1](#fig1){ref-type="fig"} shows the timeline of the animal experiments.

2.2. Hypoxic-Ischemic Injury Model {#sec2.2}
----------------------------------

To induce HI injury, 7-day-old rats underwent a left common carotid artery ligation followed by exposure to 8% O~2~ for 2 hours, as previously described \[[@B25], [@B26]\]. We used both sexes because it has been reported that sex does not affect the appearance of reflexes or the extent of HI-related brain injury \[[@B27]\]. In brief, we ligated the left common carotid artery under general respiratory anesthesia (2% isoflurane, 80% N~2~O, 20% O~2~). The surgical temperature was maintained at 36.5--37.5°C using a Panlab temperature controlled heating mat (Harvard Apparatus, Holliston, MA). The rats were then placed in a hypoxic chamber for 2 hours. The chamber was maintained at 37 ± 0.5°C and contained an 8% O~2~/N~2~ mixture. Sham animals were anesthetized and incised but did not undergo arterial occlusion or induced hypoxia. After inducing HI injury, rat pups were returned to their mother for recovery and growth for 3 weeks. Body weight was measured 3 weeks after HI injury and monitored for 6 weeks after injury.

2.3. Constraint-Induced Movement Therapy {#sec2.3}
----------------------------------------

The unaffected forelimb in the CIMT group was constrained using a pouch, as previously described \[[@B25]\]. The rats were forced to use the affected forelimb on a motorized treadmill with a slope of 15° and a speed of 10 m/min ([Figure 1(b)](#fig1){ref-type="fig"}). CIMT began 3 weeks after HI injury and was conducted for 10 minutes per day, 4 days per week, for 4 weeks.

2.4. Electroacupuncture {#sec2.4}
-----------------------

EA treatment was also initiated 3 weeks after HI injury. The acupoints at Baihui (GV 20) and Zusanli (ST 36) were electrically stimulated ([Figure 1(c)](#fig1){ref-type="fig"}) with 2 Hz, 1 mA for 20 minutes per day, 4 days per week, for 4 weeks. Baihui (GV 20) is located at the midpoint of the parietal bone, based on the eyes and ears. Zusanli (ST 36) is located about 5 mm below the knee joint and is located at the anterior part between the tibia and the fibula \[[@B28], [@B29]\]. Electrical stimulation was conducted using a Pulse master Multichannel Stimulator SYS-A300 electrical stimulator (Word Precision Instruments, Berlin, Germany).

2.5. Cylinder Test {#sec2.5}
------------------

Cylinder test, also known as the spontaneous forelimb use asymmetry test, was performed to evaluate the spontaneous use of forelimb by recording the number of forelimb contacts during exploring the Plexiglas cylinder \[[@B30]\]. Rats were placed in a transparent Plexiglas cylinder (20 cm diameter, 30 cm height). The test is terminated when a total of 20 spontaneous forelimb-contacts (20 paws) are in the wall without time restriction. For evaluation, the preference of the rat\'s initial forepaw (left/right/both) was scored during rearing behavior. The forelimb asymmetry score was calculated as follows: (left − right)/total of 20 contacts.

2.6. Analysis of Brain Atrophy {#sec2.6}
------------------------------

All rats were anesthetized with isoflurane and perfused with cold PBS followed by fixation with 4% paraformaldehyde. The brain of each rat was extracted, and an image was immediately taken of the whole brain. Nissl staining was performed to measure the volumes of atrophy in each region of the brain. Briefly, the isolated brains were fixed with 4% paraformaldehyde at 4°C for 24 hours and were then dehydrated with 30% glucose for 72 hours. All brains were frozen in an optical cutting temperature medium (Sakura Finetek, Torrance, CA) and stored at −80°C until examination. Frozen brains were cut into 20 *μ*m sections using a CM 3050 cryostat (Leica Microsystems, Wetzlar, Germany). The tissue slices were stored in a storage buffer (30% ethylene glycol and 0.01% polyvinylpyrrolidone phosphate-pH 7.4) at −20°C until analysis. Each area of the brain (cortex, striatum, hippocampus, and midbrain) was measured using iSolution full image analysis software (Image & Microscope Technology, Vancouver, Canada).

2.7. Immunohistochemistry {#sec2.7}
-------------------------

All sections (20 *μ*m) were stored in a storage buffer (30% ethylene glycol and 0.01% polyvinylpyrrolidone phosphate-pH 7.4) and were permeabilized for 30 minutes with PBS containing 0.3% Triton X-100. The sections were then incubated in a blocking solution of PBS-T (0.1% tween-20 in PBS) with 10% normal goat serum and were then exposed to the following specific primary antibodies: NeuN (1 : 200, Abcam ab177487, United Kingdom), GFAP (1 : 200, Millipore MAB360, Billerica, MA), Iba-1 (1 : 200, Wako 019--19741, Japan), and cleaved caspase-3 (1 : 200, cell signaling technology 9661L, Beverly, MA). Sections were then incubated with Alexa fluor 488- (1 : 500, Thermo fisher A-11001 and A-11008, Waltham, MA) or Alexa fluor 594-conjugated secondary antibodies (1 : 500, Thermo fisher A-11005 and A-11037) for 2 hours in the dark. We focused on the slices locating at 1,21 and −3.60 mm from the bregma and dashed red square in the cortex indicates the photographed area (Supplementary [Figure S1](#supplementary-material-1){ref-type="supplementary-material"}). The fluorescence images were captured with a Zeiss LSM 700 laser scanning confocal device (Carl Zeiss, Jena, Germany), and image analysis was performed using ImageJ software (NIH, Bethesda, MD).

2.8. Statistical Analysis {#sec2.8}
-------------------------

Data are expressed as mean ± standard error (SEM). The differences between the sham and HI groups were evaluated using unpaired *t*-tests. Comparison between the HI and treatment groups was made using repeated measurement one- or two-way ANOVAs followed by Tukey\'s post hoc tests. A *P* value of less than 0.05 was considered statistically significant. All statistical analyses were performed using SigmaPlot 11.2 (Systat Software Inc., San Jose, CA).

3. Results {#sec3}
==========

3.1. Locomotor Asymmetry Is Improved by the Combination of CIMT and EA {#sec3.1}
----------------------------------------------------------------------

Two pups died 3 weeks after HI injury, and another 2 pups died during the CIMT and EA treatment period. Survival rate was thus 94.44% at 3 weeks and 94.11% at 6 weeks after HI (data not shown). Thirty-two pups underwent CIMT, EA, or a combination of the two for 4 weeks after HI injury ([Figure 1](#fig1){ref-type="fig"}). Body weight was similar in all groups prior to treatment and did not significantly decrease in any of the groups throughout the period of measurement ([Figure 2(a)](#fig2){ref-type="fig"}).

Rehabilitation of locomotor asymmetry after HI was investigated using the cylinder test ([Figure 2(b)](#fig2){ref-type="fig"}). The HI group preferred the use of the unaffected forelimb compared to the sham group. Use of the affected forelimb in the HI/CIMT group was significantly increased at 5 weeks after HI, while use of the affected forelimb in the HI/CIMT + EA group was significantly increased at both 5 and 6 weeks after HI. These results suggest that the combined treatment of CIMT and EA increases the use of the affected limb and thus improves forelimb asymmetry.

3.2. The Combination of CIMT and EA Does Not Effectively Treat Brain Atrophy {#sec3.2}
----------------------------------------------------------------------------

We investigated the ability of combined CIMT and EA to reduce cerebral atrophy following HI injury ([Figure 3](#fig3){ref-type="fig"}). In the HI group, all investigated regions of the brain had atrophied and were found to be damaged ([Figure 3(a)](#fig3){ref-type="fig"}). Brain atrophy in the ipsilateral regions was not changed in any of the treatment groups (CIMT alone, EA alone, or a combination of the two; [Figure 3(b)](#fig3){ref-type="fig"}). We also measured the areas of several contralateral regions of the brain, including the cortex, striatum, hippocampus, and midbrain and found no differences among the groups in these regions ([Figure 3(c)](#fig3){ref-type="fig"}).

3.3. Combination of CIMT and EA Inversely Regulates the Number of Neurons and Astrocytes in the Cortex {#sec3.3}
------------------------------------------------------------------------------------------------------

As forelimb asymmetry was improved by combination of CIMT with EA ([Figure 2(b)](#fig2){ref-type="fig"}), we investigated the effect of combination treatment on neuron, astrocyte, and microglia in the motor and sensory cortex ([Figure 4](#fig4){ref-type="fig"}). NeuN (a neuronal marker) was significantly decreased in the HI group versus the sham group. The number of NeuN-expressing cells was not significantly higher in the HI/CIMT and HI/EA groups versus the HI group, but NeuN was significantly increased in the group that received a combined treatment of CIMT and EA (Figures [4(a)](#fig4){ref-type="fig"} and [4(b)](#fig4){ref-type="fig"}). Further, the expression of GFAP, a marker for astrocytes, was remarkably higher in the HI group versus the sham group and was significantly lower in the HI/CIMT + EA group versus the HI group (Figures [4(a)](#fig4){ref-type="fig"} and [4(c)](#fig4){ref-type="fig"}). Iba-1, a microglial marker, was slightly higher in the HI group versus the sham group, but no significant change was observed in the treatment groups versus the HI group (Figures [4(a)](#fig4){ref-type="fig"} and [4(d)](#fig4){ref-type="fig"}). [Figure 5](#fig5){ref-type="fig"} shows the distributions of NeuN and GFAP and shows the opposing expression patterns between these markers. That is, NeuN was almost nonexistent in the GFAP positive areas.

3.4. Cleaved Caspase-3 Levels Decrease following Combined CIMT and EA {#sec3.4}
---------------------------------------------------------------------

Cleaved caspase-3 levels are known to increase in the brain after neonatal HI injury \[[@B31]--[@B33]\]; therefore, we investigated whether cleaved caspase-3 levels were altered by CIMT or EA in our neonatal HI model. Cleaved caspase-3 levels were significantly higher in the HI injury group compared with the sham group ([Figure 6](#fig6){ref-type="fig"}), and the levels were smaller in both the CIMT and the EA groups compared with the HI group, although these differences were not significant. Further, cleaved caspase-3 levels were significantly smaller in the group that received a combination of CIMT and EA compared to the HI group ([Figure 6](#fig6){ref-type="fig"}). This suggests that a combination of CIMT and EA suppresses caspase-3 and neural cell death in the cortical area after HI injury.

4. Discussion {#sec4}
=============

In this study, we investigated the efficacy of combined CIMT and EA by analyzing body weight, motor function, volumetric changes, and histological markers in a rat model of neonatal HI. Our results show that asymmetric locomotor activity was restored through a combination of CIMT and EA. In addition, we observed increased neurons, decreased astrocytes, and reduced cleaved caspase-3 in the cortical area of the HI/CIMT + EA group.

HI brain injury is associated with approximately 25% of neonatal deaths globally \[[@B34], [@B35]\]. In cases of survival, HI injury causes severe, long-term neurological disorders in infants and children, including cerebral palsy and motor and cognitive deficits \[[@B3], [@B4]\]. Oxidative stress might be an important contributing factor in perinatal HI brain injury \[[@B4]\], causing an inflammatory response, apoptosis, and necrosis in the neural environment. Therefore, it is crucial to develop an effective treatment to overcome neonatal HI defects.

We found a significant improvement in functional outcomes in the combination CIMT and EA group ([Figure 2](#fig2){ref-type="fig"}). CIMT forcibly increased functional use of the damaged arm after HI injury and after stroke \[[@B17], [@B36]\]. The effects of this therapy can change depending on the intensity of exercise, stress, and motivation \[[@B8], [@B17]\]. We previously developed a modified CIMT method that was shown to be more effective using repeated exercise during a short treatment time \[[@B25]\]. However, CIMT alone was only minimally effective for functional recovery in a rat HI model \[[@B25]\]. Similar to our results, several reports have shown that CIMT alone does not enhance recovery in an ischemic stroke model \[[@B37], [@B38]\], although the application of both CIMT and growth factors, such as brain-derived neurotrophic factor (BDNF) or granulocyte-colony stimulating factor, has been shown to improve outcomes after experimental stroke \[[@B37], [@B38]\]. Further, when CIMT was combined with an enriched environment, neurogenesis was enhanced and functional outcomes were improved \[[@B39]\].

In the current study, we examined the combined effect of CIMT and EA in an experimental model of neonatal HI. EA has been known to stimulate neurotrophic factors in neurological diseases, including stroke \[[@B19]\]. EA improves functional outcomes by increasing the expression of BDNF, glial cell line-derived neurotrophic factor (GDNF), and insulin-like growth factor-1 \[[@B22], [@B40], [@B41]\]. It was also reported that EA stimulation improved neuromotor functional recovery and cognitive deficits after ischemic stroke in mice \[[@B42]\]. EA treatment is known to be effective in brain chemistry alteration through the secretion of neurotransmitters and neurohormones and the regulation of blood flow and body temperature around the acupoints \[[@B43]\]. In particular, the acupuncture point of Baihui (GV20) is located in the governor vessels \[[@B44]\] and is mainly used for the treatment of headache, stroke, dizziness, and anxiety. It is also used in ordinary psychological problems because this point shows sedative and harmonizing effects \[[@B44]\]. Zusanli (ST36) is an acupoint located in the stomach median \[[@B45], [@B46]\]. In the papers by Fang et al. \[[@B47]\], Zusanli (ST36) stimulates the nucleus of the solitary tract. In addition, Zusanli (ST36) affects brain activity and improves gastric mobility, gastric secretion, and gastric electrical activity \[[@B45], [@B46]\]. The results of the Zusanli studies in stroke are mostly involved in stimulating the cell survival mediators, inhibition of immune cell activity, and apoptosis in the infarction area, rather than activating specific nerves \[[@B48], [@B49]\]. Therefore, we assumed that acupoints of Baihui and Zusanli activate the nervous system by inducing the secretion of neurotransmitters or neuromodulators from the brain or spinal cord rather than activating specific nerves.

Cell death in response to neonatal HI occurs via distinct types of apoptosis, necrosis, autophagy, and chronic immune response. If this environment is not corrected within a limited time, necrosis and cell death result in nerve damage, functional damage, and death \[[@B50]\]. Upregulated GFAP expression occurs in the damaged area after neonatal HI and stroke \[[@B51]\]. GFAP has been considered a "pan-astrocytic" marker, and an increase in GFAP expression is thus an indicator of an increase in reactive astrocytes \[[@B51]\]. Reactive astrocytes occur in the vicinity of microglia and immune cells, resulting in cytotoxic inflammation \[[@B52]\]. Reactive astrocytes can lead to neuronal cell death by inducing neurotoxicity and permanent damage due to glial scar formation \[[@B52]\]. We observed that the combination of CIMT and EA decreased GFAP positive astrocytes and increased neurons in the cortex (Figures [4](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"}). In addition, the combination of CIMT and EA decreased cleaved caspase-3 levels in the cortex ([Figure 6](#fig6){ref-type="fig"}). It has been reported that EA inhibits cerebral ischemic damage by inhibiting reactive gliosis \[[@B53]\] and that CIMT reduces postischemic astrogliosis \[[@B38]\]. Therefore, we speculate that combined CIMT and EA suppress reactive astrocytes and reduce cell death after HI injury. Further experiments should be conducted to clarify the mechanisms by which a combination of CIMT and EA decreases neurotoxicity in a neonatal HI model.

5. Conclusion {#sec5}
=============

Our findings show the synergistic effect of combining CIMT with EA compared with applying either of these treatments alone. We suggest that an appropriate combination of various rehabilitation therapies, such as CIMT and EA, is more effective to obtain functional recovery in neonatal HI.
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Supplementary Figure S1. Dashed red square indicates the photographed area.

###### 

Click here for additional data file.

![*Experimental timeline of combined CIMT and EA.* (a) Post-HI injury rat pups (7 days old) were treated with CIMT alone, EA alone, or a combination of CIMT and EA for 4 weeks. (b) To perform CIMT, the unaffected forelimb was restrained by a pouch, and use of the affected forelimb was forced by a motorized treadmill. CIMT was conducted at 3 weeks after HI injury, 10 min per day, 4 days per week, for 4 weeks. (c) EA was administered at acupoints Baihui (GV 20) and Zusanli (ST 36) 20 min per day, 4 days per week, for 4 weeks.](BMRI2018-8638294.001){#fig1}

![*Effects of CIMT and EA on body weight and cylinder test*. Five groups were examined. (1) No HI injury or treatment (Sham: *n* = 10), (2) HI injury (HI: *n* = 9), (3) HI injury and CIMT (HI/CIMT: *n* = 9), (4) HI injury and EA (HI/EA: *n* = 9), and (5) HI injury and combined CIMT and EA (HI/CIMT + EA: *n* = 9). (a) Body weight was observed for 3 weeks after induced HI injury. (b) The use of the preferred forelimb during rearing for the cylinder test. ^\#^ *P* \< 0.05, ^\#\#^ *P* \< 0.01, and ^\#\#\#^ *P* \< 0.001 versus the sham group (unpaired *t*-test). ^*∗*^ *P* \< 0.05 versus the HI group (two-way repeated measures ANOVA).](BMRI2018-8638294.002){#fig2}

![*The combination of CIMT and EA was not effective for reversal of brain atrophy*. (a) Gross photos of the damaged whole brains. (b, c) Brain atrophy was confirmed using Nissl staining and the areas of the cortex, striatum, hippocampus, and midbrain were measured. *N* = 6-7 (per group), ^\#^ *P* \< 0.05 versus sham group (unpaired *t*-test).](BMRI2018-8638294.003){#fig3}

![*The numbers of neurons and astrocytes were inversely regulated by combined CIMT and EA*. (a) Immunofluorescence staining for NeuN (neuron marker), GFAP (astrocyte marker), and Iba-1 (labels microglia) in the cortex. Magnification = ×200. Scale bar = 20 *μ*m. (b, c, d) Graphs show number or integrated optical density (IOD) of NeuN, GFAP, and Iba-1 (*N* = 6). ^\#^ *P* \< 0.05 and ^\#\#\#^ *P* \< 0.001 versus the sham group (unpaired *t*-test). ^*∗*^ *P* \< 0.05 versus the HI group (one-way repeated measures ANOVA).](BMRI2018-8638294.004){#fig4}

![*Immunofluorescence staining for NeuN and GFAP in the cortex*. Double-labeling of NeuN (green) and GFAP (red) shows exclusive expression patterns. Magnification = ×200. Scale bar = 20 *μ*m.](BMRI2018-8638294.005){#fig5}

![*Cleaved caspase-3 levels were lower in the group that received combined CIMT and EA after HI injury*. (a) Representative confocal images of cleaved caspase-3 (red) in the cortex. Magnification = ×400. Scale bar = 20 *μ*m. (b) Quantification of cleaved caspase-3 levels in the cortex (*N* = 6). ^\#\#\#^ *P* \< 0.001 versus the sham group (unpaired *t*-test). ^*∗*^ *P* \< 0.05 versus the HI group (one-way repeated measures ANOVA).](BMRI2018-8638294.006){#fig6}
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